Long-term outcomes of Acute Myeloid Leukemia in adults in Pakistan

G. N. Kakepoto, I. A. Burney, S. Zaki, S. N. Adil, M. Khurshid

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To describe the long-term outcomes of Acute Myeloid Leukemia (AML) and to study clinicopathological features at presentation, morphological subtypes and remission rates. Methods: Demographic information, response to therapy and survival of patients (>14 years of age) admitted between January 1988 to August 1996 with acute myeloid leukaemia was retrieved and analysed. Results: Seventy-four patients were admitted with a diagnosis of AML during the study period. There were 43 males and 31 females. Age ranged between 15 and 70 years with a mean age of 38 years. The most common presenting feature was fever (67.5%) and the morphological subtype according to French-American-British Group (FAB) criteria was M4. Fifty-five patients received treatment and were evaluable for response and outcomes. Thirty-six (65.4%) patients had complete remission. Sixteen (29.1%) died during the first 28 days after starting induction chemotherapy. The median survival was 11 months. Six (11%) patients (4 females, 2 males) are surviving beyond 4 years (long-term survivors). Conclusion: Our study suggests that the long-term outcomes of adults with AML are comparable to what has been reported in the literature for patients who do not receive bone marrow transplants.

Original languageEnglish
Pages (from-to)482-486
Number of pages5
JournalJournal of the Pakistan Medical Association
Volume52
Issue number10
Publication statusPublished - Oct 1 2002

Fingerprint

Pakistan
Acute Myeloid Leukemia
Induction Chemotherapy
Survival
Survivors
Fever
Bone Marrow
Demography
Transplants
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kakepoto, G. N., Burney, I. A., Zaki, S., Adil, S. N., & Khurshid, M. (2002). Long-term outcomes of Acute Myeloid Leukemia in adults in Pakistan. Journal of the Pakistan Medical Association, 52(10), 482-486.

Long-term outcomes of Acute Myeloid Leukemia in adults in Pakistan. / Kakepoto, G. N.; Burney, I. A.; Zaki, S.; Adil, S. N.; Khurshid, M.

In: Journal of the Pakistan Medical Association, Vol. 52, No. 10, 01.10.2002, p. 482-486.

Research output: Contribution to journalArticle

Kakepoto, GN, Burney, IA, Zaki, S, Adil, SN & Khurshid, M 2002, 'Long-term outcomes of Acute Myeloid Leukemia in adults in Pakistan', Journal of the Pakistan Medical Association, vol. 52, no. 10, pp. 482-486.
Kakepoto, G. N. ; Burney, I. A. ; Zaki, S. ; Adil, S. N. ; Khurshid, M. / Long-term outcomes of Acute Myeloid Leukemia in adults in Pakistan. In: Journal of the Pakistan Medical Association. 2002 ; Vol. 52, No. 10. pp. 482-486.
@article{6a84ad7813664cd5b8a303ba30c2e848,
title = "Long-term outcomes of Acute Myeloid Leukemia in adults in Pakistan",
abstract = "Objective: To describe the long-term outcomes of Acute Myeloid Leukemia (AML) and to study clinicopathological features at presentation, morphological subtypes and remission rates. Methods: Demographic information, response to therapy and survival of patients (>14 years of age) admitted between January 1988 to August 1996 with acute myeloid leukaemia was retrieved and analysed. Results: Seventy-four patients were admitted with a diagnosis of AML during the study period. There were 43 males and 31 females. Age ranged between 15 and 70 years with a mean age of 38 years. The most common presenting feature was fever (67.5{\%}) and the morphological subtype according to French-American-British Group (FAB) criteria was M4. Fifty-five patients received treatment and were evaluable for response and outcomes. Thirty-six (65.4{\%}) patients had complete remission. Sixteen (29.1{\%}) died during the first 28 days after starting induction chemotherapy. The median survival was 11 months. Six (11{\%}) patients (4 females, 2 males) are surviving beyond 4 years (long-term survivors). Conclusion: Our study suggests that the long-term outcomes of adults with AML are comparable to what has been reported in the literature for patients who do not receive bone marrow transplants.",
author = "Kakepoto, {G. N.} and Burney, {I. A.} and S. Zaki and Adil, {S. N.} and M. Khurshid",
year = "2002",
month = "10",
day = "1",
language = "English",
volume = "52",
pages = "482--486",
journal = "JPMA. The Journal of the Pakistan Medical Association",
issn = "0030-9982",
publisher = "Pakistan Medical Association",
number = "10",

}

TY - JOUR

T1 - Long-term outcomes of Acute Myeloid Leukemia in adults in Pakistan

AU - Kakepoto, G. N.

AU - Burney, I. A.

AU - Zaki, S.

AU - Adil, S. N.

AU - Khurshid, M.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Objective: To describe the long-term outcomes of Acute Myeloid Leukemia (AML) and to study clinicopathological features at presentation, morphological subtypes and remission rates. Methods: Demographic information, response to therapy and survival of patients (>14 years of age) admitted between January 1988 to August 1996 with acute myeloid leukaemia was retrieved and analysed. Results: Seventy-four patients were admitted with a diagnosis of AML during the study period. There were 43 males and 31 females. Age ranged between 15 and 70 years with a mean age of 38 years. The most common presenting feature was fever (67.5%) and the morphological subtype according to French-American-British Group (FAB) criteria was M4. Fifty-five patients received treatment and were evaluable for response and outcomes. Thirty-six (65.4%) patients had complete remission. Sixteen (29.1%) died during the first 28 days after starting induction chemotherapy. The median survival was 11 months. Six (11%) patients (4 females, 2 males) are surviving beyond 4 years (long-term survivors). Conclusion: Our study suggests that the long-term outcomes of adults with AML are comparable to what has been reported in the literature for patients who do not receive bone marrow transplants.

AB - Objective: To describe the long-term outcomes of Acute Myeloid Leukemia (AML) and to study clinicopathological features at presentation, morphological subtypes and remission rates. Methods: Demographic information, response to therapy and survival of patients (>14 years of age) admitted between January 1988 to August 1996 with acute myeloid leukaemia was retrieved and analysed. Results: Seventy-four patients were admitted with a diagnosis of AML during the study period. There were 43 males and 31 females. Age ranged between 15 and 70 years with a mean age of 38 years. The most common presenting feature was fever (67.5%) and the morphological subtype according to French-American-British Group (FAB) criteria was M4. Fifty-five patients received treatment and were evaluable for response and outcomes. Thirty-six (65.4%) patients had complete remission. Sixteen (29.1%) died during the first 28 days after starting induction chemotherapy. The median survival was 11 months. Six (11%) patients (4 females, 2 males) are surviving beyond 4 years (long-term survivors). Conclusion: Our study suggests that the long-term outcomes of adults with AML are comparable to what has been reported in the literature for patients who do not receive bone marrow transplants.

UR - http://www.scopus.com/inward/record.url?scp=0036823442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036823442&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 482

EP - 486

JO - JPMA. The Journal of the Pakistan Medical Association

JF - JPMA. The Journal of the Pakistan Medical Association

SN - 0030-9982

IS - 10

ER -